Home
About us
Services
Clients
News-Events
Team
Contact
Strategic intelligence for the radiation healthcare
Bringing value to businesses and investors!
Proton Therapy
Nuclear Medicine
Brachytherapy
Nuclear Medicine

Nuclear Medicine continues to gain increasing attention worldwide, with a growing number of radiopharmaceuticals being marketed
or under development, with scanners offering more precise images and new accelerators becoming smaller, providing higher yield
and able to produce a new range of radioisotopes and more importantly with an increasing interest for therapy.

Detailed table of contents and sample pages available upon request
at peg@medraysintell.com


Published
December 2015
Cyclotrons used in Nuclear Medicine
World Market Report & Directory, Edition 2015



This 350-page report provides an extensive review of all cyclotrons around the world with an exhaustive profile of the 14 companies active in this market.

This first edition of the Cyclotrons Report and Directory is the result of a comprehensive collection of data over the past year that allowed MEDraysintell to identify as many as 1,218 cyclotrons (status MEDraysintell end of November 2015) dedicated to the production of medical radionuclides installed worldwide, in addition to 66 cyclotrons which are known to having been decommissioned or transfered.

Click the image to download the information sheet

 

Published
June 2015


Nuclear Medicine World Market Report & Directory, Edition 2015

Radionuclides, Radiopharmaceuticals,
Market Pipeline and R&D Portfolio,
Market Data, Product Pricing, Companies Profiles

Second edition of the most comprehensive evaluation report and directory of nuclear medicine, written by experts, providing detailed information on products and companies active in this market.


This 930-page document is providing a description and analysis of 335 radiopharmaceuticals and radionuclides and 160 companies and institutions active in nuclear medicine.. 
The report presents real opportunities with detailed analysis.
The global nuclear medicine market is expected to reach US$ 24 billion by
2030, showing an annual average growth of 11%.


Click the image to download the information sheet

See also a short presentation
HERE


     


A first edition of the Nuclear Medicine report “Opportunities in Nuclear Medicine”, was published in March 2014. Clients’ feedback praised the outstanding level of this report.



HomeAbout usServicesClientsNews-EventsTeamContact
© 2016 MEDraysintell